These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21157405)

  • 1. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation.
    Iwase H; Kobayashi T; Kodera Y; Miwa Y; Kuzuya T; Iwasaki K; Haneda M; Katayama A; Takeda A; Morozumi K; Watarai Y; Uchida K; Nakao A
    Transplantation; 2011 Jan; 91(2):191-8. PubMed ID: 21157405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
    Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
    Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
    Liu L; Deng S; Teng L; Fu Q; Wang C; He X
    Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
    van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
    Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
    Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome.
    Braudeau C; Racape M; Giral M; Louis S; Moreau A; Berthelot L; Heslan M; Ashton-Chess J; Soulillou JP; Brouard S
    Transpl Int; 2007 Oct; 20(10):845-55. PubMed ID: 17854443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?
    Batsford S; Dickenmann M; Dürmüller U; Hopfer H; Gudat F; Mihatsch M
    Clin Nephrol; 2011 Feb; 75(2):101-6. PubMed ID: 21255538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.
    Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P
    Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.
    Kollins D; Stoelcker B; Hoffmann U; Bergler T; Reinhold S; Banas MC; Rümmele P; Farkas S; Krämer BK; Banas B
    Clin Nephrol; 2011 Feb; 75(2):91-100. PubMed ID: 21255537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Foxp3+ regulatory T cells in kidney transplantation.
    Karczewski M; Karczewski J; Kostrzewa A; Wiktorowicz K; Glyda M
    Transplant Proc; 2009 Jun; 41(5):1527-9. PubMed ID: 19545671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.
    Wang W; Li XB; Yang XY; Zhang XD
    Chin Med J (Engl); 2011 Jun; 124(12):1775-8. PubMed ID: 21740831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals.
    Moraes-Vieira PM; Silva HM; Takenaka MC; Monteiro SM; Lemos F; Saitovitch D; Kalil J; Coelho V
    Hum Immunol; 2010 May; 71(5):442-50. PubMed ID: 20122976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
    Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection.
    Grimbert P; Mansour H; Desvaux D; Roudot-Thoraval F; Audard V; Dahan K; Berrehar F; Dehoulle-Poillet C; Farcet JP; Lang P; Le Gouvello S
    Transplantation; 2007 Feb; 83(3):341-6. PubMed ID: 17297410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
    Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
    Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.